Use of Beta Blockers in the Patient With Diabetes
- 1 March 2003
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in The Endocrinologist
- Vol. 13 (2), 116-123
- https://doi.org/10.1097/01.ten.0000076214.95014.05
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational studyBMJ, 2000
- Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects.Diabetes Care, 2000
- β-Adrenergic Blocking Agents in Patients With Diabetes—Friend and FoeEndocrine Practice, 1999
- Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38BMJ, 1998
- Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial InfarctionNew England Journal of Medicine, 1998
- Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trialThe Lancet, 1998
- The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressureArchives of Internal Medicine, 1997
- Pulse rate, coronary heart disease, and death: The NHANES I Epidemiologic Follow-up StudyAmerican Heart Journal, 1991
- Diabetic patients and beta-blockers after acute myocardial infarctionEuropean Heart Journal, 1990